Panel: Addressing The Industry’s Challenges with Data Quality, Access & Regulatory Acceptance Across Europe
Time: 9:30 am
day: Day One
Details:
- Exploring the evolving European regulatory framework and its impact on the acceptance of real-world evidence in drug development and clinical trials
- Addressing data privacy concerns and ensuring compliance with European data protection regulations
- Manoeuvring methods to break down databases and improve data quality for more effective real-world evidence utilisation
Moderated By: Lene Hammer-Helmich, Director, Head of RWE & Epidemiology, Lundbeck
